NM_020717.5:c.1675G>A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_020717.5(SHROOM4):c.1675G>A(p.Glu559Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000519 in 1,209,155 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 212 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020717.5 missense
Scores
Clinical Significance
Conservation
Publications
- X-linked intellectual disability, Stocco dos Santos typeInheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- complex neurodevelopmental disorderInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020717.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SHROOM4 | NM_020717.5 | MANE Select | c.1675G>A | p.Glu559Lys | missense | Exon 4 of 9 | NP_065768.2 | ||
| SHROOM4 | NR_027121.3 | n.1851G>A | non_coding_transcript_exon | Exon 4 of 10 | |||||
| SHROOM4 | NR_172068.1 | n.1716G>A | non_coding_transcript_exon | Exon 3 of 9 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SHROOM4 | ENST00000376020.9 | TSL:2 MANE Select | c.1675G>A | p.Glu559Lys | missense | Exon 4 of 9 | ENSP00000365188.2 | ||
| SHROOM4 | ENST00000289292.11 | TSL:1 | c.1675G>A | p.Glu559Lys | missense | Exon 4 of 10 | ENSP00000289292.7 | ||
| SHROOM4 | ENST00000460112.3 | TSL:5 | c.1327G>A | p.Glu443Lys | missense | Exon 3 of 8 | ENSP00000421450.1 |
Frequencies
GnomAD3 genomes AF: 0.000386 AC: 43AN: 111437Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000315 AC: 57AN: 180846 AF XY: 0.000244 show subpopulations
GnomAD4 exome AF: 0.000533 AC: 585AN: 1097663Hom.: 0 Cov.: 33 AF XY: 0.000559 AC XY: 203AN XY: 363039 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000386 AC: 43AN: 111492Hom.: 0 Cov.: 22 AF XY: 0.000267 AC XY: 9AN XY: 33688 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
SHROOM4: BP4, BS2
not specified Uncertain:2
The c.1675G>A (p.E559K) alteration is located in exon 4 (coding exon 4) of the SHROOM4 gene. This alteration results from a G to A substitution at nucleotide position 1675, causing the glutamic acid (E) at amino acid position 559 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at